Changes
/* GSK-3 Inhibition */
# differential usage of isoforms or splice variants to alter subcellular localization or substrate specificity
# integration of parellel signals conveyed by a signal stimulus.
'''Key Finding'''
* Pyrazole compounds with nhibition constant (Ki) of <0.1 mM are a good starting point for developing molecules that can inhibit serine/threonine protein kinase (such as GSK-3) and the proteins they help to regulate. [http://www.chemistry.org/portal/a/c/s/1/acsdisplay.html?DOC=patentwatch%5Carchive%5C011204_patentwatch.html source]
== Conclusions ==
Anonymous user
